Apyx Medical Corp Right-of-Use Asset Obtained in Exchange for Finance Lease Liability
Apyx Medical Corp (APYX) reported Right-of-Use Asset Obtained in Exchange for Finance Lease Liability of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-21.
Discontinued › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability · last filed 2024-03-21
- Apyx Medical Corp right-of-use asset obtained in exchange for finance lease liability for the quarter ending 2023-12-31 was $0.00.
- Apyx Medical Corp right-of-use asset obtained in exchange for finance lease liability for the quarter ending 2023-09-30 was $0.00.
- Apyx Medical Corp right-of-use asset obtained in exchange for finance lease liability for the quarter ending 2022-12-31 was $0.00.
- Apyx Medical Corp right-of-use asset obtained in exchange for finance lease liability for the quarter ending 2022-09-30 was $0.00.
- Apyx Medical Corp right-of-use asset obtained in exchange for finance lease liability for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Apyx Medical Corp right-of-use asset obtained in exchange for finance lease liability for fiscal 2022 was $103.00K.
| Period end | Right-of-Use Asset Obtained in Exchange for Finance Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Finance Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Finance Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Finance Lease Liability 9 month as first filed | Right-of-Use Asset Obtained in Exchange for Finance Lease Liability 12 month |
|---|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $0.00 derived: sum of 2 quarters · filed 2024-03-21 | $0.00 10-K · filed 2024-03-21 | ||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | |||
| 2023-06-30 | $0.00 10-Q · filed 2023-08-11 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $0.00 derived: sum of 2 quarters · filed 2024-03-21 | $103.00K 10-K · filed 2024-03-21 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $103.00K 10-Q · filed 2023-11-09 | $28.00K 10-Q · filed 2022-11-10 | ||
| 2022-06-30 | $103.00K 10-Q · filed 2023-08-11 | ||||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |